MERCURY LABORATORIES
|
The Current P/E Ratio of MERCURY LABORATORIES is 24.03.
Share Price | ₹1,000.5 | Sep 19,2024 |
Market Cap | ₹120.1 Cr | |
Earnings-TTM | ₹5.0 Cr | TTM-Standalone Results |
Price/Earnings | 24.03x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MERCURY LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹120.1 Cr] as on Sep 19,2024
(/) Earnings [ ₹5.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 24.03x ]
Thus, for MERCURY LABORATORIES , the investors are currently willing to pay 24.03 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MERCURY LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MERCURY LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of MERCURY LABORATORIES
PE Ratio Performance Analysis for MERCURY LABORATORIES
- MERCURY LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 13.63x.
- MERCURY LABORATORIES 's operated at median p/e ratio of 14.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MERCURY LABORATORIES 's p/e ratio peaked in Mar2022 at 16.34x.
- MERCURY LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 10.45x.
How does MERCURY LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MERCURY LABORATORIES | 5.00 | 24.03 | 120.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,506.70 | 42.17 | 443,025.0 |
CIPLA LTD | 4,335.02 | 30.52 | 132,316.0 |
DR REDDYS LABORATORIES LTD | 5,549.00 | 19.57 | 108,579.0 |
ZYDUS LIFESCIENCES LTD | 4,181.90 | 25.37 | 106,092.0 |
DIVIS LABORATORIES LTD | 1,674.00 | 86.20 | 144,299.0 |
MANKIND PHARMA LTD | 1,976.25 | 49.28 | 97,396.6 |
TORRENT PHARMACEUTICALS LTD | 1,735.00 | 65.36 | 113,401.0 |
LUPIN LTD | 2,287.78 | 43.27 | 98,990.9 |
AUROBINDO PHARMA LTD | 3,533.22 | 25.11 | 88,708.7 |
ABBOTT INDIA LTD | 1,238.99 | 47.96 | 59,419.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MERCURY LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.57x |
Max industry PE | 86.20x |
Median industry PE | 42.17x |
Average industry PE | 41.71x |
You may also like the below Video Courses